When people discuss “fat stem cells” they usually mean “stromal vascular fraction” or SVF. While references to fat or adipose stem cells can sometimes mean non-SVF materials, these days adipose SVF gets the most attention. But, does anyone have a clear picture of this biologic? Fortunately, it’s starting to come more into focus in recent years …
A big, fat elephant in “the room” of the commercial stem cell field today is something called stromal vascular fraction or SVF, made from human fat tissue or adipose. If you care at all about stem cells or the stem cell field more generally, you had better educate yourself on SVF. You can learn a …
Law and Order SVF: what is stromal vascular fraction? Read More »
Today I am posting Part 2 of my interview with Drs. Lander and Berman of the Cell Surgical Network. You can read Part 1 here, which is an interesting look inside the Network. The final portion of this blog post series, Part 3, is my take on their answers and you might not be surprised that …
Cell Surgical Network Interview Part 2: SVF, FDA, & Homologous Use Read More »
What’s the deal with IntelliCell Biosciences, headed up by Dr. Steven Victor? Sometimes science can move at warp speed and that is even more true of the stem cell field. One stem cell establishment that seems to be in a particularly intense period of activity and that has drawn a great deal of attention lately …
Interview with Dr. Steven Victor of IntelliCell Biosciences (SVFC) Read More »
In the past week I’ve been getting an unprecedented number of emails, blog comments, and even phone calls about IntelliCell Biosciences of NY (stock symbol SVFC). It’s quite remarkable and I’ve had to moderate many comments related to IntelliCell for content not following this blog’s comment rules. The grapevine is smoking hot on this company. It’s …
Stem Cell Grapevine on Fire: Big Day & Week Ahead for IntelliCell (SVFC) Read More »
What the heck is going on with Intellicell Biosystems, Inc. (SVFC, also SVFCE), a stem cell corporation run by Dr. Steven Victor? Why are some on Wall Street seeming so bullish on the company lately? What’s the real story and the facts? What is the key background on this company? Wall Street has been buying …
Wall Street Weirdness Over Stem Cell Biotech Intellicell (SVFC) Read More »
Two emerging acronyms in the for-profit stem cell world that remain unknown to most academic stem cell scientists, but that are generating the most buzz are: SVF and CAL. These are two fat acronyms. What? These acronyms relate to adipose (fat) stem cell-based procedures. SVF stands for “stromal vascular fraction”. SVF is, for lack of …
SVF & CAL are two fat stem cell acronyms generating a lot of buzz Read More »
I was able to watch some of the 9th Circuit Court hearing today on the FDA appeal of its loss in the Cell Surgical Network lawsuit. This post is my brief impressions as a scientist. What went down? Do the three judges seem to be leaning one way or another? The ruling in this case …
9th Circuit hearing on FDA appeal of Cell Surgical Network case: maybe encouraging? Read More »
There has been a steady stream of encouraging data on stem cells for MS. Particularly for certain kinds of MS. A new study adds to this upbeat direction. Good news on stem cells for MS Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study, Journal of Neurology, Neurosurgery, …
Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit Read More »
The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers. The story also bears on the doctors and hospitals like Weill Cornell that were or are customers of the suppliers. Further, what is the FDA’s role in all of this? The …
Burst Biologics unapproved biologic used by Weill Cornell: was there a cover-up? Read More »